FDA NDC Directory · JSON-LD · Markdown

Ketamine Hydrochloride

NDC 0409-2053 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Labeler / ManufacturerHospira, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA074549
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAMUSCULAR INTRAVENOUS
Active ingredientsKETAMINE HYDROCHLORIDE (50 mg/mL)
Marketing started20041130
Package count1

External sources

Source: openFDA. Public-domain (CC0).